相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Coronary heart disease outcomes in patients receiving antidiabetic agents
Andrew T. McAfee et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Effect of enzyme replacement therapy with imiglucerase on BMD in type 1 Gaucher disease
Richard J. Wenstrup et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Superior effects of high-dose enzyme replacement therapy in type 1 Gaucher disease on bone marrow involvement and chitotriosidase levels:: a 2-center retrospective analysis
Maaike de Fost et al.
BLOOD (2006)
Individualization of long-term enzyme replacement therapy for Gaucher disease
HC Andersson et al.
GENETICS IN MEDICINE (2005)
Gaucher disease and bone: Laboratory and skeletal mineral density variations during a long period of enzyme replacement therapy
G Ciana et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2005)
Gaucher disease: alendronate disodium improves bone mineral density in adults receiving enzyme therapy
RJ Wenstrup et al.
BLOOD (2004)
Enzyme replacement therapy and monitoring for children with type 1 Gaucher disease: Consensus recommendations
J Charrow et al.
JOURNAL OF PEDIATRICS (2004)
Gaucher disease type 1:: Revised recommendations on evaluations and monitoring for adult patients
NJ Weinreb et al.
SEMINARS IN HEMATOLOGY (2004)
The multiple propensity score for analysis of dose-response relationships in drug safety studies
JX Wang et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2001)
The Gaucher registry -: Demographics and disease characteristics of 1698 patients with Gaucher disease
J Charrow et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Comparative efficacy of dose regimens in enzyme replacement therapy of type I Gaucher disease
G Altarescu et al.
BLOOD CELLS MOLECULES AND DISEASES (2000)
分享论文
